While the Aristocrat Leisure Limited (ASX: ALL) share price may be going gangbusters this month and climbing to an all-time high, not all shares have fared so well.
In fact, the three shares below have just fallen to 52-week lows. Are they in the bargain bin now?
The Compumedics Limited (ASX: CMP) share price has fallen a massive 61% this year and currently sits at a 52-week low of 33 cents. The medical equipment company's shares came under heavy selling pressure in February after it posted its half-year results. A shortfall in sales in the United States led to a 50% drop in EBITDA to $1.2 million. This was especially disappointing considering management had previously stated that it expected EBITDA growth of 20% in FY 2017. While Compumedics is an interesting company with a lot of promise, I would hold off an investment until there are signs of improvement.
The Mayne Pharma Group Ltd (ASX: MYX) share price continued its decline last week and sunk to a 52-week low of 99 cents. Incredibly this means its shares have lost 34% of their value since the day before the company announced its acquisition of 37 approved and five FDA-filed products from Teva Pharmaceutical Industries and Allergan for US$652 million last year. Concerns that President Trump may shake up the industry by forcing significant price cuts on generic drugs appears to be behind the slump. Whilst I'm a big fan of Mayne Pharma and think the company has a number of valuable assets, until Trump's plans are finalised I would suggest investors avoid the company's shares.
The Yowie Group Ltd (ASX: YOW) share price fell to a multi-year low of 29 cents on Friday of last week. Weaker-than-expected sales in the U.S. and news that it is likely to go to trial for an alleged breach of its manufacturing agreement have weighed heavily on its shares. While the confectionery company could prove to be a bargain buy at the current share price, I would suggest investors wait for an improvement in its sales performance and also the outcome of the aforementioned trial.
